Clinical Trial Update: Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic and safety study evaluating GZR4 injection in adults with hepatic impairment, in the context of diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• GZR4 Injection (GZR4)

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Diabetes | Phase 1 | Status: ACTIVE_NOT_RECRUITING